SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Transaction in Own Shares

3 Apr 2025 18:15

RNS Number : 6160D
BioPharma Credit PLC
03 April 2025
Β 

BioPharma Credit plc

(the "Company")

TRANSACTION IN OWN SHARES

Β 

BioPharma Credit PLC announces that today it has purchased the following number of its ordinary shares of US $0.01 each through J.P. Morgan Securities plc into treasury.

Β 

Β 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 500,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: JPMSI

Β 

Β 

Ordinary Shares: BPCR LN

Date of purchase: 3 April 2025

Number of ordinary shares purchased: 50,000

Lowest price per share: $0.8700

Highest price per share: $0.8700

Trading venue: LSE

Β 

Β 

Aggregate volume per date per trading venue: 550,000

Weighted average price per day per trading venue: $0.8737

Β 

Following the above transaction, the Company holds 244,207,072 of its ordinary shares in treasury and has 1,129,724,995 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,129,724,995. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Β 

Β 

Enquiries:

BioPharma Credit plc

viaΒ MUFG Corporate Governance Limited

Company Secretary

+44 (0) 333 300 1932

Burson Buchanan

Mark Court /Β Jamie HooperΒ / Henry Wilson / Samuel Adams

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

Β 

Notes to Editors:

Β 

BioPharma Credit PLCΒ isΒ London'sΒ only specialist debt investor to the life sciences industry and joined the LSE inΒ March 2017.Β BioPharma Credit PLCΒ seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry.Β BioPharma Credit PLCΒ seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

Β 

Β 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSQXLFBEZLLBBE
Date   Source Headline
11th Mar 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Mar 20243:10 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Full Year Results
26th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20246:15 pmRNSTransaction in Own Shares
19th Feb 20246:15 pmRNSTransaction in Own Shares
16th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20247:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
9th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20247:00 amRNSDividend Declaration
7th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
1st Feb 202410:39 amRNSTotal Voting Rights
31st Jan 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Jan 20246:15 pmRNSTransaction in Own Shares
29th Jan 20246:15 pmRNSTransaction in Own Shares
26th Jan 20246:15 pmRNSTransaction in Own Shares
25th Jan 20246:15 pmRNSTransaction in Own Shares
24th Jan 20246:15 pmRNSTransaction in Own Shares
23rd Jan 20246:15 pmRNSTransaction in Own Shares
22nd Jan 20246:15 pmRNSTransaction in Own Shares
22nd Jan 202412:35 pmRNSDirector/PDMR Shareholding
19th Jan 20246:15 pmRNSTransaction in Own Shares
18th Jan 20246:15 pmRNSTransaction in Own Shares
17th Jan 20246:15 pmRNSTransaction in Own Shares
16th Jan 20246:15 pmRNSTransaction in Own Shares
15th Jan 20246:15 pmRNSTransaction in Own Shares
12th Jan 20246:15 pmRNSTransaction in Own Shares
11th Jan 20246:15 pmRNSTransaction in Own Shares
10th Jan 20246:15 pmRNSTransaction in Own Shares
10th Jan 202410:36 amRNSTransaction in Own Shares
8th Jan 20246:15 pmRNSTransaction in Own Shares
5th Jan 20246:15 pmRNSTransaction in Own Shares
3rd Jan 20246:15 pmRNSTransaction in Own Shares
2nd Jan 20246:15 pmRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSUPDATE ON INVESTMENT
28th Dec 202311:04 amRNSResult of General Meeting
21st Dec 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Dec 202311:25 amRNSUPDATE ON INVESTMENT
7th Dec 20236:04 pmRNSPUBLICATION OF CIRCULAR AND NOTICE OF GM
1st Dec 20237:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
29th Nov 20237:00 amRNSDIVIDEND DECLARATION
22nd Nov 20237:01 amRNSUPDATE ON INVESTMENT
22nd Nov 20237:00 amRNSNET ASSET VALUE(S)
2nd Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSUPDATE ON INVESTMENT
1st Nov 20237:00 amRNSTRIGGER OF A CONTINUATION RESOLUTION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.